The effect of losartan therapy on ventricular function in Marfan patients with haploinsufficient or dominant negative FBN1 mutations

A. W. den Hartog, R. Franken, M. P. van den Berg, A. H. Zwinderman, J. Timmermans, A. J. Scholte, V. de Waard, A. M. Spijkerboer, G. Pals, B. J. M. Mulder, M. Groenink

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)675-681
JournalNetherlands Heart Journal
Volume24
Issue number11
DOIs
Publication statusPublished - Nov 2016

Keywords

  • Marfan syndrome
  • Ventricular function
  • Ventricular volumes
  • Losartan
  • Cardiac magnetic resonance imaging
  • FBN1 mutation classes

Cite this

den Hartog, A. W., Franken, R., van den Berg, M. P., Zwinderman, A. H., Timmermans, J., Scholte, A. J., de Waard, V., Spijkerboer, A. M., Pals, G., Mulder, B. J. M., & Groenink, M. (2016). The effect of losartan therapy on ventricular function in Marfan patients with haploinsufficient or dominant negative FBN1 mutations. Netherlands Heart Journal, 24(11), 675-681. https://doi.org/10.1007/s12471-016-0905-8